secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuBase Therapeutics, Inc. (—)
CIK:        0001173281
Form:       8-K
Filed at:   2024-04-05T23:59:59+00:00
Accession:  0001104659-24-044287
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuBase receives Nasdaq non-compliance notice for late 10-K filing; has until June 3 to submit plan
--------------------------------------------------------------------------------

- Failed to file Annual Report on Form 10-K for FY2023 ended Dec 31, 2023.
- Received notice from Nasdaq on April 4, 2024; listing not immediately affected.
- Must submit compliance plan by June 3, 2024; if accepted, exception may extend to Sept 30, 2024.
- Failure to regain compliance could result in delisting of NBSE common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173281/000110465924044287/0001104659-24-044287-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173281/000110465924044287/tm2411211d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-044287

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer